Home Tools
Log in
Cart

Decarboxylase

Carboxy-lyases, also known as decarboxylases, are carbon–carbon lyases that add or remove a carboxyl group from organic compounds. These enzymes catalyze the decarboxylation of amino acids, beta-keto acids and alpha-keto acids.
Cat. No. Product name CAS No. Purity Chemical Structure
T17166 Tritoqualine 14504-73-5 98%
Tritoqualine is used as an inhibitor of histidine decarboxylase.
T0737 L-Ornithine 70-26-8 98%
L-ornithine has an anti-fatigue function in facilitating the excretion of ammonia and increasing the efficiency of energy consumption.
T2593 Eflornithine hydrochloride hydrate 96020-91-6 98%
Eflornithine hydrochloride is a specific, irreversible inhibitor of ornithine decarboxylase.
T7454 4-Bromo-3-hydroxybenzoic acid 14348-38-0 98%
4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase.
T6795 Carbidopa 28860-95-9 98%
Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
T2148 Carbidopa monohydrate 38821-49-7 98%
Carbidopa Hydrate is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.
Tritoqualine
T17166
Tritoqualine is used as an inhibitor of histidine decarboxylase.
L-Ornithine
T0737
L-ornithine has an anti-fatigue function in facilitating the excretion of ammonia and increasing the efficiency of energy consumption.
Eflornithine hydrochloride hydrate
T2593
Eflornithine hydrochloride is a specific, irreversible inhibitor of ornithine decarboxylase.
4-Bromo-3-hydroxybenzoic acid
T7454
4-bromo-3-hydroxybenzoic acid is a potent inhibitor of the enzyme histidine decarboxylase.
Carbidopa
T6795
Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
Carbidopa monohydrate
T2148
Carbidopa Hydrate is an inhibitor of DOPA decarboxylase, preventing the conversion of levodopa to dopamine.